Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.93B | 2.71B | 2.94B | 3.53B | 3.43B |
Gross Profit | 2.07B | 1.91B | 2.11B | 2.42B | 2.14B |
EBITDA | 20.62M | 242.60M | -33.16M | 185.13M | 255.05M |
Net Income | 43.01M | 160.31M | -384.61M | 40.38M | -23.23M |
Balance Sheet | |||||
Total Assets | 3.57B | 3.57B | 3.85B | 4.35B | 4.72B |
Cash, Cash Equivalents and Short-Term Investments | 577.94M | 208.73M | 247.67M | 129.38M | 113.43M |
Total Debt | 339.85M | 451.69M | 1.05B | 1.18B | 1.79B |
Total Liabilities | 1.10B | 1.33B | 1.87B | 2.09B | 3.20B |
Stockholders Equity | 2.47B | 2.24B | 1.98B | 2.27B | 1.51B |
Cash Flow | |||||
Free Cash Flow | 424.68M | 408.70M | 243.33M | -160.58M | 374.53M |
Operating Cash Flow | 445.94M | 453.06M | 278.59M | -107.06M | 427.02M |
Investing Cash Flow | -18.43M | 7.30M | -29.30M | 63.30M | 330.37M |
Financing Cash Flow | -58.27M | -499.31M | -131.00M | 59.71M | -693.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | ¥1.75B | 5.21 | ― | 8.96% | ― | ||
62 Neutral | $20.56B | 14.66 | -3.18% | 3.15% | 1.93% | -6.58% | |
― | $452.94M | 43.21 | 3.06% | 1.55% | ― | ― | |
73 Outperform | ¥41.37B | 28.93 | 1.43% | 6.10% | 13.84% | ||
63 Neutral | ¥6.60B | 10.31 | 2.29% | -3.27% | ― | ||
60 Neutral | ¥6.16B | 159.76 | 1.56% | -9.81% | ― | ||
45 Neutral | ¥5.16B | 20.49 | 1.66% | 7.21% | ― |
Ivy Cosmetics Corporation reported a significant decline in its financial performance for the first quarter ending June 2025. The company experienced a 15.7% decrease in net sales compared to the previous year, alongside operating and ordinary losses. Despite these challenges, the capital adequacy ratio improved to 74.9%, indicating a strong equity position. The company did not declare any dividends for the quarter, reflecting its focus on stabilizing operations amidst financial setbacks.
Ivy Cosmetics Corporation reported a significant increase in operating and ordinary profits for the fiscal year ending March 2025, with operating profit rising by 125.9% and ordinary profit by 124.2%. Despite a decline in net profit by 73.2%, the company improved its capital adequacy ratio to 69.2%, indicating a stronger financial position, which may positively impact its market standing and stakeholder confidence.